In this episode, Manu Nair, Co-Founder and CEO of EtherealX, breaks down the engineering breakthroughs, fundraising battles, and geopolitical forces reshaping the future of space tech in India and beyond.

Over 85% of the world's commercial satellite launches depend on a single rocket from a single country. That's not a monopoly - it's a dependency, and Manu Nair believes it is one of the most dangerous structural flaws in global space infrastructure today. Manu is the Co-Founder and CEO of EtherealX, the Bengaluru-based deep tech startup building the Razor Crest Mk-1 - India's first fully reusable medium-lift launch vehicle that recovers both its booster and upper stage.

In a conversation with host Akshay Datt, Manu traces the journey from bootstrapping on personal savings and a loan from his father, to closing a $20.5 million Series A co-led by TDK Ventures and Accel, to signing binding launch agreements with Japanese, Taiwanese, and European space agencies. He reveals the proprietary rocket engine cycle EtherealX developed, the first new feed cycle in six decades of rocketry, which harnesses re-entry plasma heat as a thermodynamic resource rather than fighting it with heavy ceramic shields.

He also shares why the economics of partial reusability are a dead end, why super-heavy rockets make no commercial sense for everyday satellite deployment, and why EtherealX's long-term roadmap extends from orbital launch vehicles all the way to small modular nuclear reactors.

A candid, technically rich, and deeply inspiring episode at the intersection of space tech, deep tech investing, India's policy renaissance, and civilisational ambition.

Key Highlights

👉Why 85% of global payloads riding one rocket is a civilisational risk, and how EtherealX is building the alternative the world needs

👉The FFSCC breakthrough - how EtherealX invented a new rocket engine cycle that turns re-entry heat into fuel, enabling full upper-stage recovery for the first time in the medium-lift class

👉How Manu and his co-founders bootstrapped for a year, raised a $360K milestone round, and eventually closed $26.3 million across four rounds to build India's highest pressure-rated private rocket engine test facility

👉Why the economics of large rockets like Starship don't work for routine commercial LEO deployment, and why the medium-lift segment will remain the engine of the global space economy for the next decade

👉India's regulatory renaissance - the FDI reforms, the Rs 1,000 crore IN-SPACe VC fund, and how ISRO's shift from gatekeeper to enabler created the conditions for EtherealX to exist

👉Why EtherealX's long-term roadmap includes fusion-based small modular reactors to power AI data centres on Earth, and why putting data centres in orbit is a dangerous mistake

#ManuJNair #EtherealX #EtherealExplorationGuild #FounderThesis #AkshayDatt #ReusableRocket #IndiaSpaceTech #SpaceTechStartupIndia #RazorCrestMk1 #DeepTechIndia #SpaceXAlternative #IndiaSpaceStartup #MediumLiftRocket #FFSCC #IndiaSpacePolicy #INSPACe #MultipolanSpaceAccess #SpaceFundingIndia #DeepTechFunding2025 #ReusableLaunchVehicle #FounderStoryIndia #IndiaStartupFunding #SmallModularReactors #SpaceTechPodcast #StartupPodcastIndia #ISROPrivateSector #IndiaDeepTech2025

Disclaimer: The views expressed are those of the speaker, not necessarily the channel

In this episode, we uncover how Priyadarshi Mohapatra turned CureBay into one of India's most ambitious rural healthtech ventures, raising $37M and proving that Bharat will pay for quality care.

Priyadarshi Mohapatra has spent 25 years building businesses that others said couldn't be built. From co-creating the Tanishq brand's iconic purity positioning to scaling Microsoft's consumer division and leading Google Cloud's India enterprise push, he has always found opportunity where others saw obstacles.

Then COVID hit, and a broken Skype teleconsultation attempt for his wife ignited an idea that would become CureBay, a hybrid phygital platform delivering last-mile primary healthcare to rural India through a network of 200 AI-powered eClinics across Odisha, Chhattisgarh and Jharkhand.

In a candid, wide-ranging conversation with host Akshay Datt, Priyadarshi unpacks the structural failures of India's rural healthcare system, the unit economics of the Kavach membership program, the Swasthya Mitra distribution model and why he believes 100 CureBays are needed to truly solve this problem. This episode is essential listening for anyone tracking India's $45 billion rural health market, the future of AI in healthcare, and the next wave of impact-driven startups reshaping Bharat.

What you'll learn in this episode:

👉Why India's rural healthcare crisis is not a funding problem but a trust and access problem, and how CureBay's hybrid eClinic model solves both at once

👉How the Kavach membership program, priced at just Rs 499 per year, is built like an insurance product and is already seeing 60% renewal rates

👉The real reason doctors refuse to serve rural India, and why no policy mandate has been able to fix the structural economics behind it

👉How CureBay is training AI models on real patient data from 200 clinics to build diagnostics tools that outperform anything trained on synthetic data

👉Why Priyadarshi believes partnering with government, not competing with it, is the only way to build healthcare at scale in India

👉The "nodal point" strategy that replaced his early mistake of going too deep into single villages, and how speed of execution became his sharpest competitive weapon

If this episode gave you a new lens on India's rural health opportunity, subscribe to Founder Thesis so you never miss a conversation like this one. And follow host Akshay Datt on LinkedIn and X for daily insights on India's most ambitious founders and the startups they are building.

Chapters:

00:00 - Why Rural India's Healthcare System Is Broken

08:20 - The Doctor Shortage Nobody Can Fix

14:00 - How CureBay's eClinic Model Actually Works

24:30 - Kavach, The Rs 499 Plan Rewriting Rural Health Insurance

37:45 - Funding CureBay, The $37M Journey

43:00 - From Tanishq to Google to Village Clinics

54:00 - AI and Data, CureBay's Secret Long Game

1:03:00 - Why India Needs 100 CureBays

#PriyadarshiMohapatra #CureBay #RuralHealthcareIndia #HealthtechIndia #IndiaStartups #FounderThesis #AkshayDatt #PhygitalHealthcare #RuralBharat #AyushmanBharat #AIinHealthcare #ImpactInvesting #IndiaHealthtech #StartupFunding #SeriesBFunding #SwasthyaMitra #KavachMembership #TeleconsultationIndia #LastMileHealthcare #BharatStartups #HealthtechDisruption #RuralIndiaHealthcare #IndiaHealthcareMarket #StartupIndia #ImpactStartupsIndia

Disclaimer: The views expressed are those of the speaker, not necessarily the channel

Pranav Pai, Founding Partner and CIO of 3one4 Capital, has spent a decade betting on Indian founders at the earliest possible stage, often when they are just two people on a laptop.

From backing Licious when 50 investors said no, to spotting Darwinbox before enterprise HR software was considered a credible category in India, Pranav has built a track record that speaks for itself, including a 6x Fund I return, a single-digit loss ratio in a market where 30 to 45 percent of VC capital typically goes to zero, and five unicorns across a $570M portfolio.

In a candid, wide-ranging conversation with host Akshay Datt, Pranav shares why he deliberately caps fund size, how he fires people for persistent poor judgment, and why AI can now write your investment thesis but can never replace genuine market instinct. He also delivers one of the sharpest takes on India's foundational AI debate, the myth of the vegetarian Indian consumer, and what it actually takes to build a performance culture inside a VC firm.

What you will learn in this episode:

👉How Pranav Pai and 3one4 Capital built India's highest-performing early-stage VC fund without an investment banking or IIT pedigree, by betting on operators over financiers

👉Why 3one4 turned down capital to stay sub-$250M, and the precise mathematical logic that makes fund size a performance variable, not a vanity metric

👉The real story behind the Licious and Darwinbox investments, two of India's most celebrated startup bets, both rejected by 50-plus investors before 3one4 said yes

👉How Pranav evaluates founders using three non-negotiable criteria, including one he rarely admits publicly, and why pain and anger are features, not red flags

👉Why AI can write a 90 percent accurate investment thesis today, what that means for the future of VC as a profession, and where the actual edge now lives

👉Pranav's unfiltered view on India's AI sovereignty debate, the $10 trillion GDP trajectory, and the third path India must take between the US and China models

If you found this conversation valuable, subscribe to the Founder Thesis Podcast so you never miss an episode. Follow host Akshay Datt on LinkedIn and X for sharp takes on Indian startups, venture capital, and the founders building India's next decade.

Chapters

00:00 - Pranav Pai's Journey Into Indian VC

05:10 - Why 3one4 Capital Stays Sub $250M

13:00 - The Math Behind Fund Size and Returns

20:30 - How 3one4 Backed Licious Against All Odds

31:00 - Prepared Minds: Luck vs Decision Quality

37:00 - Darwinbox, Decision Logs and Firing for Bad Judgment

47:00 - How to Judge Founders at the Seed Stage

01:03:00 - Two Unicorns in Fund One: The Inside Story

01:09:00 - What VCs Actually Need to Be Great At

01:17:00 - Pain, Anger and the Fuel Behind Great Founders

01:25:00 - Market Truth, AI and the New VC Edge

01:39:00 - 3one4's Four Big Investment Themes for the Next Decade

#PranavPai #3one4Capital #FounderThesisPodcast #IndianVentureCapital #VCIndia #IndiaStartups #EarlyStageVC #StartupFunding #Licious #Darwinbox #UnicornIndia #IndiaVC2025 #VentureCapitalIndia #StartupIndia #IndianFounders #FundingIndia #AIStartupsIndia #IndiaStartupEcosystem #VCFundStrategy #AkshayDatt #HomegrownVC #IndiaGDPGrowth #DecisionQuality #FounderEvaluation #SeedFundingIndia

Disclaimer: The views expressed are those of the speaker, not necessarily the channel